Jaguar Health Eliminates 11 Series of Preferred Stock

On September 15, 2026, Jaguar Health, Inc. filed a Certificate of Elimination with the Secretary of State of Delaware to remove 11 series of preferred stock from its charter. The eliminated series include the Series B-2 Convertible Preferred Stock, Series C Perpetual Preferred Stock, Series D Perpetual Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Convertible Preferred Stock, Series H Convertible Preferred Stock, Series I Convertible Preferred Stock, Series J Perpetual Preferred Stock, Series K Junior Participating Preferred Stock, Series L Perpetual Preferred Stock, Series M Perpetual Preferred Stock, Series N Perpetual Preferred Stock, and Series O Convertible Preferred Stock.

The filing states that all outstanding shares of these specified series had been converted, exchanged, or otherwise disposed of prior to September 15, 2026. Consequently, no shares of any of the specified series were outstanding immediately before the filing of the Certificate of Elimination. The elimination returns the shares to authorized but undesignated shares of the Company’s preferred stock.

In a related event, the Company previously disclosed that it effected a 1-for-15 reverse stock split of its common stock on September 17, 2026. Following the completion of this reverse split, the Company had approximately 520,088 outstanding shares of common stock.